These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 5582283)
1. Biochemical mechanisms of drug resistance. IV. Development of resistance to 5-azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice. Veselý J; Cihák A; Sorm F Int J Cancer; 1967 Nov; 2(6):639-46. PubMed ID: 5582283 [No Abstract] [Full Text] [Related]
2. Biochemical mechanism of drug resistance. VII. Inhibition of orotic acid metabolism by 5-azacytidine in leukemic mice sensitive and resistant to 5-azacytidine. Veselý J; Cihák A; Sorm F Biochem Pharmacol; 1968 Apr; 17(4):519-24. PubMed ID: 5649551 [No Abstract] [Full Text] [Related]
3. Characteristics of mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. Veselý J; Cihák A; Sorm F Cancer Res; 1968 Oct; 28(10):1995-2000. PubMed ID: 5696931 [No Abstract] [Full Text] [Related]
4. Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine. Cihák A; Veselý J; Sorm F Biochim Biophys Acta; 1965 Nov; 108(3):516-8. PubMed ID: 5867538 [No Abstract] [Full Text] [Related]
5. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection. Mulkins MA; Heidelberger C Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554 [TBL] [Abstract][Full Text] [Related]
6. Pyrimidine metabolism in man. V. The measurement in vivo of the biochemical effect of antineoplastic agents in animal and human subjects. RABKIN MT; FREDERICK EW; LOTZ M; SMITH LH J Clin Invest; 1962 Apr; 41(4):871-83. PubMed ID: 14489640 [No Abstract] [Full Text] [Related]
7. Regulatory mechanisms linked with RNA synthesis of avian leukaemic myeloblasts. I. Changes in the activity of pyrimidine ribonucleoside kinases. Seifert J; Ríman J Neoplasma; 1966; 13(4):391-402. PubMed ID: 5919706 [No Abstract] [Full Text] [Related]
9. [Clinical pharmacology of anticancer agents (Part 4). Antimetabolites (1)]. Nakamura T; Uchida M; Ueda T Gan To Kagaku Ryoho; 1992 Feb; 19(2):265-76. PubMed ID: 1736842 [TBL] [Abstract][Full Text] [Related]
10. OXONATE AND OTHER RELATED ANTIMETABOLITES OF THE SYNTHESIS DE NOVO OF PYRIMIDINE NUCLEOTIDES. HANDSCHUMACHER RE Acta Unio Int Contra Cancrum; 1964; 20():1051-3. PubMed ID: 14274691 [No Abstract] [Full Text] [Related]
11. Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines. Mulkins MA; Heidelberger C Cancer Res; 1982 Mar; 42(3):965-73. PubMed ID: 7059992 [TBL] [Abstract][Full Text] [Related]
12. Biochemical changes associated with the development of resistance to 5-azacytidine in AKR leukemic mice. Veselý J; Seifert J; Cihák A; Sorm F Int J Cancer; 1966 Jan; 1(1):31-9. PubMed ID: 5902317 [No Abstract] [Full Text] [Related]
13. Biochemical mechanisms of drug resistance. 3. Differences in the metabolism of mouse leukaemic cells sensitive and resistant to 5-azacytidine. Sorm F; Veselý J; Cihák A Acta Biochim Pol; 1966; 13(4):385-94. PubMed ID: 5962444 [No Abstract] [Full Text] [Related]
14. Degradation of pyrimidines and pyrimidine analogs--pathways and mutual influences. Wasternack C Pharmacol Ther; 1980; 8(3):629-51. PubMed ID: 6992162 [No Abstract] [Full Text] [Related]
15. Uptake and binding of vincristine by murine leukemia cells. Bleyer WA; Frisby SA; Oliverio VT Biochem Pharmacol; 1975 Mar; 24(5):633-9. PubMed ID: 1168475 [No Abstract] [Full Text] [Related]
16. THE EFFECT OF 6-AZAURIDINE AND 6-AZACYTIDINE ON THE INTRACELLULAR SYNTHESIS OF RNA IN FOWL LEUKEMIC AND NORMAL MYELOBLASTS IN VITRO. VESELY J Acta Biol Med Ger; 1964; 12():60-6. PubMed ID: 14140504 [No Abstract] [Full Text] [Related]
17. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Tidd DM; Paterson AR Cancer Res; 1974 Apr; 34(4):738-46. PubMed ID: 4856046 [No Abstract] [Full Text] [Related]
18. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts. Grant S; Cadman E Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541 [TBL] [Abstract][Full Text] [Related]
19. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis. Grant S; Bhalla K; Gleyzer M Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998 [TBL] [Abstract][Full Text] [Related]
20. Role of catabolism in pyrimidine utilization for nucleic acid synthesis in vivo. Cooper GM; Dunning WF; Greer S Cancer Res; 1972 Feb; 32(2):390-7. PubMed ID: 5058194 [No Abstract] [Full Text] [Related] [Next] [New Search]